Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.47 |
| ▸ | NPC1 | O15118 | 4/20 | 0.47 |
| ▸ | RAB9A | P51151 | 4/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.47 |
| ▸ | CASP3 | P42574 | 2/20 | 0.47 |
| ▸ | SENP8 | Q96LD8 | 2/20 | 0.47 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 0.47 |
| ▸ | SENP6 | Q9GZR1 | 2/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | PARG | Q86W56 | 1/20 | 0.38 |
| ▸ | USP8 | P40818 | 3/20 | 0.38 |
| ▸ | USP7 | Q93009 | 2/20 | 0.38 |
| ▸ | USP47 | Q96K76 | 1/20 | 0.36 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.35 |
| ▸ | BCL2 | P10415 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.35 |
| ▸ | MAPT | P10636 | 5/20 | 0.35 |
| ▸ | POLB | P06746 | 2/20 | 0.35 |
| ▸ | HTT | P42858 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29399456 | 1.00 | LMNA (0.47) | LMNANPC1RAB9ASMN1; SMN2MAPK1 | |
| SCHEMBL28333502 | 0.75 | RAB9A (0.56) | LMNANPC1RAB9ASMN1; SMN2MAPK1 | |
| SCHEMBL29496222 | 0.74 | MEN1 (0.55) | LMNANPC1RAB9ASMN1; SMN2MAPK1 | |
| SCHEMBL187098 | 0.74 | MEN1 (0.55) | LMNANPC1RAB9ASMN1; SMN2MAPK1 | |
| SCHEMBL10696799 | 0.72 | RAB9A (0.39) | LMNANPC1RAB9ASMN1; SMN2MAPK1 | |
| SCHEMBL8405065 | 0.71 | APAF1 (0.52) | LMNANPC1RAB9ASMN1; SMN2MAPK1 | |
| SCHEMBL28383679 | 0.70 | USP8 (0.50) | LMNANPC1RAB9ASMN1; SMN2MAPK1 | |
| Anthraquinone SCHEMBL28722242 | 0.68 | RAB9A (0.71) | LMNANPC1RAB9ASMN1; SMN2MAPK1 | |
| SCHEMBL10967500 | 0.67 | ALDH1A1 (0.50) | LMNASMN1; SMN2USP8USP7USP47 | |
| SCHEMBL7854282 | 0.67 | USP8 (0.37) | LMNANPC1RAB9ASMN1; SMN2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 170 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2533633-B1 | FUNGICIDAL MIXTURES | LANXESS DISTRIB GMBH (DE) | 2017-02-01 | — | — | EP | claimed |
| US-20130195997-A1 | FUNGICIDAL MIXTURES | LANXESS DISTRIBUTION GMBH (DE) | 2013-08-01 | — | — | US | claimed |
| US-20110319435-A1 | FUNGICIDE MIXTURES | LANXESS DISTRIBUTION GMBH (DE) | 2011-12-29 | — | — | US | claimed |
| EP-2153720-A1 | Fungicide mixtures comprising formate | LANXESS Distribution GmbH (DE) | 2010-02-17 | — | — | EP | claimed |
| CN-113395898-A | Compositions for treating citrus disease and promoting yield enhancement of row crops | 斯波根生物技术公司 | 2021-09-14 | — | — | CN | disclosed |
| CN-111491654-A | Biologically active polypeptides for improving the protection, growth and productivity of plants | 斯波根生物技术公司 | 2020-08-04 | — | — | CN | disclosed |
| EP-2533633-B1 | FUNGICIDAL MIXTURES | LANXESS DISTRIB GMBH (DE) | 2017-02-01 | — | — | EP | disclosed |
| US-20160152578-A1 | CRYSTALLINE MODIFICATIONS OF PROTHIOCONAZOLE | ADAMA MAKHTESHIM LTD (IL) | 2016-06-02 | — | — | US | disclosed |
| US-9326514-B2 | Fungicidal active substance combinations containing trifloxystrobin | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2016-05-03 | — | — | US | disclosed |
| US-9290461-B2 | Crystalline modifications of prothioconazole | ADAMA MAKHTESHIM LTD (IL) | 2016-03-22 | — | — | US | disclosed |
| CN-104478814-A | Crystalline modifications of prothioconazole | MAKHTESHIM CHEM WORKS LTD | 2015-04-01 | — | — | CN | disclosed |
| CN-102083802-B | Crystal modification of prothioconazole | MAKHTESHIM CHEM WORKS LTD | 2015-02-04 | — | — | CN | disclosed |
| US-20030040540-A1 | For use as biocides for protecting plants and industrial materials | BAYER AKTIENGESELLSCHAFT (DE) | 2003-02-27 | — | — | US | disclosed |
| WO-2003010149-A1 | PYRAZOLYLCARBOXANILIDES AS FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2003-02-06 | — | — | WO | disclosed |
| WO-2002068413-A1 | PYRAZOLYL PYRIMIDINES | BAYER CROPSCIENCE AG (DE) | 2002-09-06 | — | — | WO | disclosed |
| US-6369093-B1 | Pyrazole carboxanilide fungicide | BAYER AKTIENGESELLSCHAFT (DE) | 2002-04-09 | — | — | US | disclosed |
| WO-2002006259-A1 | HETEROCYCLIC FLUOROALKENYL THIOETHERS AND THE USE THEREOF AS PESTICIDES (IV) | BAYER CROPSCIENCE AG (DE) | 2002-01-24 | — | — | WO | disclosed |
| WO-2002006257-A1 | HETEROCYCLIC FLUOROALKENYL THIOETHERS AND THE USE THEREOF AS PESTICIDES (III) | BAYER CROPSCIENCE AG (DE) | 2002-01-24 | — | — | WO | disclosed |
| WO-2002006256-A1 | HETEROCYCLIC FLUOROALKENYL THIOETHERS (II) | BAYER CROPSCIENCE AG (DE) | 2002-01-24 | — | — | WO | disclosed |
| US-6001879-A | SUITABLE FOR CONTROLLING PESTS, PREFERABLY FUNGI, INSECTS AND BACTERIA, IN PLANTS AND INDUSTRIAL MATERIALS; METHODS OF THEIR SYBNTHESIS INCLUDING REACTING AMINOSALICYLAMIDES WITH ACYLATING AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 1999-12-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030040540-A1 | For use as biocides for protecting plants and industrial materials | BROX, GPX1, PRDX3 | LMNA 3259/4885NPC1 1458/4885RAB9A 2044/4885 |
| US-20160152578-A1 | CRYSTALLINE MODIFICATIONS OF PROTHIOCONAZOLE | RPL23A, CASP3, NOX3 | LMNA 1164/4885NPC1 1251/4885RAB9A 3357/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.